XLRN Stock Recent News
XLRN LATEST HEADLINES
Merck stock jumped Monday after a drug its acquired for billions scored a "must-win" in patients with a rare blood pressure condition. The post Merck Scores A 'Must-Win' For Its $11.5 Billion Acceleron Buyout appeared first on Investor's Business Daily.
Investors Business Daily 2022 Oct 10
1 of 1